Table 1.
Clinical characteristics of Parkinson’s disease patients.
| Patient ID | Sex | Age (years) | Disease durationa (years) | UPDRSb (ON, OFF) | H&Y scorec (ON, OFF) | Medications |
|---|---|---|---|---|---|---|
| PD01 | F | 65 | 8 | 20, 39 | 2, 2 | Carbidopa/levodopa, pramipexole |
| PD02 | M | 70 | 17 | 47, 52 | 3, 3 | Carbidopa/levodopa, amantadine, selegiline |
| PD03 | M | 47 | 7 | 42, 58 | 3, 3 | Ropinirole XL, selegiline, rasagiline |
| PD04 | F | 70 | 7 | 30, 38 | 2, 2 | Rasagiline, pramipexole |
| PD05 | F | 68 | 3 | 22, 28 | 3, 2 | Rasagiline, carbidopa/levodopa |
| PD06 | F | 69 | 9 | 31, 37 | 3, 3 | Carbidopa/levodopa, amantadine, selegiline, pramipexole |
| PD07 | F | 66 | 4 | 36, 44 | 3, 3 | Carbidopa/levodopa, pramipexole, rasagiline |
| PD08 | M | 58 | 12 | 37, 41 | 2, 3 | Carbidopa/levodopa/entacapone; rasagiline |
| PD09 | F | 52 | 9 | 33, 43 | 3, 3 | Carbidopa/levodopa, rasagiline, amantadine, ropinirole XL |
aDuration is years since first remembered Parkinsonian symptom.
bUPDRS: United Parkinson’s Disease Rating Scale, Motor Section (maximum score of 108). Higher scores indicate greater motor impairments.
cH&Y stage: Hoehn and Yahr stage (maximum score of 5). Higher stages indicate more severe disease.